Compared with the non-mutated ones, the microenvironment of BRAF mutated tumors is characterized by a twice as high density of FOXP3+ Regulatory T cells (Tregs), which, by inhibiting the anti-tumor immune response, are associated with a poor prognosis [22]. Here, BRAF is linked to neoplasm.